VestGen Advisors’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$217K Sell
7,577
-209
-3% -$6.63K 0.01% 1005
2026
Q1
$255K Sell
7,786
-1,376
-15% -$43.4K 0.01% 909
2025
Q4
$270K Sell
9,162
-97,834
-91% -$2.72M 0.01% 625
2025
Q3
$2.7M Buy
106,996
+271
+0.3% +$6.61K 0.09% 208
2025
Q2
$2.49M Buy
106,725
+2,474
+2% +$57.4K 0.1% 189
2025
Q1
$2.39M Buy
+104,251
New +$2.52M 0.11% 168

Other funds holding RTO

VestGen Advisors's RTO Position: Q2 2026 in Review

VestGen Advisors reduced its Rentokil (RTO) stake by 2.7% in Q2 2026, selling an estimated $6.63K and leaving 7,577 shares worth $217K. The position accounts for 0.01% of the portfolio, ranked #1005.

VestGen Advisors first reported a position in RTO in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.7M in Q3 2025. 284 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • VestGen Advisors held 7,577 shares of Rentokil worth $217K as of Q2 2026.
  • VestGen Advisors sold 209 Rentokil shares in Q2 2026, an estimated $6.63K.
  • Rentokil made up 0.01% of VestGen Advisors's portfolio in Q2 2026, its #1005 holding.
  • VestGen Advisors first reported a position in Rentokil in Q1 2025 and has held it in 6 quarters since.
  • VestGen Advisors's Rentokil position peaked at $2.7M in Q3 2025.
  • 284 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on VestGen Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.